Concerto HealthAI   Report issue

For profit Phase 1 Phase 2
Founded: Memphis TN United States (2002)

Organization Overview

First Clinical Trial
2006
NCT00786643
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Vector Oncology and The West Clinic

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Chondrosarcoma (Phase 2)

Colorectal Neoplasms (Phase 2)

Genital Neoplasms, Female (Phase 1)

Liposarcoma (Phase 2)

Osteosarcoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 9